gold has been researched along with Coronary Restenosis in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (73.33) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davaran, S; Hosseini, J; Mirmohseni, A; Shojaei, M | 1 |
| Hu, J; Huang, L; Li, B; Lu, X; Peng, Z; Qin, J; Yang, X; Ye, K; Yuan, F; Zhang, Y | 1 |
| Fay, WP; Katti, K; Katti, KV; Khoobchandani, M; Maxwell, A | 1 |
| Björk, J; Bruze, M; Ekqvist, S; Lundh, T; Möller, H; Svedman, C | 1 |
| Björk, J; Bruze, M; Ekqvist, S; Gruvberger, B; Gustavsson, CG; Holmström, E; Möller, H; Pripp, CM; Svedman, C | 1 |
| Björk, J; Bruze, M; Ekqvist, S; Lundh, T; Möller, H; Nilsson, LA; Svedman, C | 1 |
| Bruze, M; Gustavsson, CG; Möller, H; Svedman, C | 1 |
| Babapulle, MN; Eisenberg, MJ | 1 |
| Benit, E; Chan, C; Cobaugh, M; Dawkins, K; de Sousa, E; Guagliumi, G; Hauptmann, KE; Kaul, U; Morice, MC; Reifart, N; Silber, S; Thuesen, L; Webb, J | 1 |
| Bruze, M; Frennby, B; Gustavsson, CG; Möller, H; Svedman, C; Tillman, C | 1 |
| Ellis, S; Honari, G; Taylor, JS | 1 |
| Dibra, A; Dirschinger, J; Kastrati, A; Mehilli, J; Pache, J; Schaut, C; Schömig, A; Schühlen, H | 1 |
| Björk, J; Bruze, M; Ekqvist, S; Gruvberger, B; Gustavsson, CG; Holmström, E; Kehler, M; Möller, H; Pripp, CM; Svedman, C | 1 |
| Antoniucci, D; Capuano, C; Danzi, GB; Di Blasi, A; Predolini, S; Sesana, M | 1 |
| Hong, MK; Jang, YS; Jeong, MH; Kim, JJ; Lee, CW; Park, SJ; Park, SW; Seung, KB; Tahk, SJ; Yang, JY | 1 |
1 review(s) available for gold and Coronary Restenosis
| Article | Year |
|---|---|
Coated stents for the prevention of restenosis: Part II.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Antineoplastic Agents; Clinical Trials as Topic; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Delayed-Action Preparations; Drug Implants; Enzyme Inhibitors; Gold; Humans; Immunosuppressive Agents; Phosphorylcholine; Secondary Prevention; Stents; Steroids; Treatment Outcome | 2002 |
4 trial(s) available for gold and Coronary Restenosis
| Article | Year |
|---|---|
Does gold concentration in the blood influence the result of patch testing to gold?
Topics: Adult; Aged; Antirheumatic Agents; Coronary Restenosis; Cross-Over Studies; Dermatitis, Allergic Contact; Female; Gold; Gold Sodium Thiosulfate; Humans; Male; Middle Aged; Patch Tests; Stents; Young Adult | 2009 |
The NUGGET study: NIR ultra gold-gilded equivalency trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Female; Follow-Up Studies; Gold; Humans; Male; Middle Aged; Postoperative Complications; Prospective Studies; Stents; Survival Analysis; Therapeutic Equivalency; Treatment Outcome; Ultrasonography, Interventional | 2004 |
Sustained increased risk of adverse cardiac events over 5 years after implantation of gold-coated coronary stents.
Topics: Aged; Blood Vessel Prosthesis Implantation; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Female; Follow-Up Studies; Germany; Gold; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Risk Factors; Stents; Survival Analysis; Time Factors; Treatment Outcome | 2006 |
Comparison of gold-coated NIR stents with uncoated NIR stents in patients with coronary artery disease.
Topics: Aged; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Gold; Humans; Korea; Male; Middle Aged; Prospective Studies; Risk; Stents | 2002 |
10 other study(ies) available for gold and Coronary Restenosis
| Article | Year |
|---|---|
Design and evaluation of mixed self-assembled monolayers for a potential use in everolimus eluting coronary stents.
Topics: Chromatography, High Pressure Liquid; Coated Materials, Biocompatible; Coronary Restenosis; Drug Delivery Systems; Drug-Eluting Stents; Everolimus; Gold; Humans; Materials Testing; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Photoelectron Spectroscopy; Quartz Crystal Microbalance Techniques; Sirolimus; Spectroscopy, Fourier Transform Infrared; Surface Properties | 2013 |
Gold nanorods as a theranostic platform for in vitro and in vivo imaging and photothermal therapy of inflammatory macrophages.
Topics: Animals; Apolipoproteins E; Cell Line; Cell Survival; Coronary Restenosis; Gold; Infrared Rays; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Electron, Transmission; Nanotubes; Phototherapy; Theranostic Nanomedicine; Tissue Distribution; X-Ray Microtomography | 2015 |
Laminin Receptor-Avid Nanotherapeutic EGCg-AuNPs as a Potential Alternative Therapeutic Approach to Prevent Restenosis.
Topics: Anti-Inflammatory Agents; Antioxidants; Catechin; Cell Line; Cell Movement; Cell Proliferation; Coronary Restenosis; Drug Carriers; Endothelial Cells; Gold; Human Umbilical Vein Endothelial Cells; Humans; Metal Nanoparticles; Myocytes, Smooth Muscle; Receptors, Laminin; Ribosomal Proteins | 2016 |
A correlation found between gold concentration in blood and patch test reactions in patients with coronary stents.
Topics: Adult; Coronary Restenosis; Dental Amalgam; Dental Restoration, Permanent; Dermatitis, Allergic Contact; Female; Gold; Gold Alloys; Humans; Male; Middle Aged; Nickel; Patch Tests; Risk Factors; Sweden | 2008 |
A correlation found between contact allergy to stent material and restenosis of the coronary arteries.
Topics: Angioplasty, Balloon, Coronary; Chi-Square Distribution; Coronary Artery Disease; Coronary Restenosis; Dermatitis, Allergic Contact; Female; Gold; Humans; Male; Recurrence; Risk Factors; Stainless Steel; Stents; Sweden | 2009 |
Coronary restenosis and contact allergy to stent material.
Topics: Coronary Restenosis; Dermatitis, Contact; Gold; Humans; Risk Factors; Stents | 2011 |
Contact allergy to gold in patients with gold-plated intracoronary stents.
Topics: Adult; Aged; Case-Control Studies; Coated Materials, Biocompatible; Coronary Restenosis; Dermatitis, Allergic Contact; Female; Gold; Humans; Male; Middle Aged; Patch Tests; Stents; Surveys and Questionnaires; Sweden | 2005 |
Contact allergy to gold in patients with gold-plated intracoronary stents.
Topics: Coated Materials, Biocompatible; Coronary Restenosis; Dermatitis, Allergic Contact; Gold; Humans; Patch Tests; Research Design; Stents; Sweden | 2005 |
High frequency of contact allergy to gold in patients with endovascular coronary stents.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Restenosis; Dermatitis, Allergic Contact; Epidemiologic Methods; Female; Gold; Humans; Male; Middle Aged; Nickel; Patch Tests; Stents | 2007 |
Patterns of in-stent restenosis after placement of NIR gold-coated stents in unselected patients.
Topics: Aged; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Female; Follow-Up Studies; Gold; Humans; Incidence; Italy; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prospective Studies; Stainless Steel; Stents; Survival Analysis; Time Factors; Treatment Outcome | 2002 |